Immunity to previously encountered viruses can alter response to unrelated pathogens. We
reasoned that similar mechanism may also involve SARS-CoV-2 and thereby affect the …

SARS-CoV-2 is a novel betacoronavirus that caused coronavirus disease 2019 and has
resulted in millions of deaths worldwide. Novel coronavirus infections in humans have …

There is an urgent need for effective treatment and preventive vaccine to contain this
devastating global pandemic, which requires a comprehensive understanding of humoral …

The clinical features of SARS-CoV-2 infection range from asymptomatic to severe disease
with life-threatening complications. Understanding the persistence of immune responses in …

Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …

Background A protective antibody response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is crucial to decrease morbidity and mortality from severe …

COVID-19 continues to cause a pandemic, having infected more than 20 million people
globally. Successful elimination of the SARS-CoV-2 virus will require an effective vaccine …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly
pathogenic and contagious coronavirus that caused a global pandemic with 5.2 million …

Long-term antibody responses to SARS-CoV-2 have focused on responses to full-length
spike protein, specific domains within spike, or nucleoprotein. In this study, we used high …